Advertisement

Newcastle Disease Vaccines

  • Miguel A. Gómez Lim
Chapter
Part of the Biotechnology in Agriculture and Forestry book series (AGRICULTURE, volume 68)

Abstract

Newcastle disease virus (NDV) is a devastating infection causing up to 100 % mortality in infected chickens. Due to its enzootic nature, prevention of the disease can be achieved effectively only through vaccination. While conventional vaccines incorporating live, attenuated virus or inactivated virus exist, recombinant vaccines are effective but more expensive. Attempts, therefore, have been made to produce recombinant oral vaccines in plants which would allow for more economical production as well as convenient administration through feed. Production of such inexpensive and effective vaccines at low cost is key to effective management of this disease for large-scale production of chickens, but also in countries where chickens are kept domestically and represent a source of family wealth and nutrition.

Keywords

Newcastle Disease Virus Highly Pathogenic Avian Influenza Oral Vaccine Highly Pathogenic Avian Influenza H5N1 Highly Pathogenic Avian Influenza H5N1 Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Abd-Alla HI, Moharram FA, Gaara AH, El-Safty MM (2009) Phytoconstituents of Jatropha curcas L. leaves and their immunomodulatory activity on humoral and cell-mediated immune response in chicks. Z Naturforsch C 64:495–501PubMedGoogle Scholar
  2. Acevedo RA, Mendoza IL (1947) Chicken embryo vaccine against Newcastle disease (pneumoencephalitis). Am J Vet Res 8:91–102PubMedGoogle Scholar
  3. Alexander DJ (1997) Newcastle disease and other avian Paramyxoviridae infections. In: Calnek BW, Barnes HJ, Beard CW, Reid WM, Yoder HW (eds) Diseases of poultry. Iowa State University Press, IowaGoogle Scholar
  4. Alexander DJ, Aldous EW, Fuller CM (2012) The long view: a selective review of 40 years of Newcastle disease research. Avian Pathol 41:329–335PubMedCrossRefGoogle Scholar
  5. Allan WH, Lancaster JE, Toth B (1978) Newcastle disease vaccines: their production and use, FAO Animal Production Series No. 10. FAO, RomeGoogle Scholar
  6. Bankowski RA (1957) A modified live Newcastle disease virus vaccine. Proc Soc Exp Biol Med 96:114–118PubMedCrossRefGoogle Scholar
  7. Ben-Nathan B, Drabkin N, Heller D (1981) The effect of starvation on the immune response of chickens. Avian Dis 25:214–217PubMedCrossRefGoogle Scholar
  8. Berinstein A, Vazquez-Rovere C, Asurmendi S, Gomez E, Zanetti F, Zabal O, Tozzini A, Grand DC, Taboga O, Calamante G, Barrios H, Hopp E, Carrillo E (2005) Mucosal and systemic immunization elicited by Newcastle disease virus (NDV) transgenic plants as antigens. Vaccine 23:5583–5589PubMedCrossRefGoogle Scholar
  9. Boursnell ME, Green PF, Campbell JI, Deuter A, Peters RW, Tomley FM, Samson AC, Chambers P, Emmerson PT, Binns MM (1990a) Insertion of the fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recombinant. J Gen Virol 71(Pt 3):621–628PubMedCrossRefGoogle Scholar
  10. Boursnell ME, Green PF, Samson AC, Campbell JI, Deuter A, Peters RW, Millar NS, Emmerson PT, Binns MM (1990b) A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV. Virology 178:297–300PubMedCrossRefGoogle Scholar
  11. Box PG (1965) The influence of maternal antibody on vaccination against Newcastle disease. Vet Rec 77:246–249CrossRefGoogle Scholar
  12. Box PG, Stedman RA, Singleton L (1969) Newcastle disease. I. The use of egg yolk derived antibody for passive immunisation of chickens. J Comp Pathol 79:495–506PubMedCrossRefGoogle Scholar
  13. Churchill AE, Blaxland JD (1966) Experiments with a live Newcastle disease vaccine administered in the drinking water of chickens. Vet Rec 79:30–35PubMedCrossRefGoogle Scholar
  14. Csatary LK, Moss RW, Beuth J, Torocsik B, Szeberenyi J, Bakacs T (1999) Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H). Anticancer Res 19:635–638PubMedGoogle Scholar
  15. Davies HM (2010) Commercialization of whole-plant systems for biomanufacturing of protein products: evolution and prospects. Plant Biotechnol J 8:845–861PubMedCrossRefGoogle Scholar
  16. Doll ER, Mc CW, Wallace ME (1951) Susceptibility to Newcastle disease infection of chickens from hens immunized with live virus vaccines. Am J Vet Res 12:232–239PubMedGoogle Scholar
  17. Doyle TM (1927) A hitherto unrecorded disease of fowls due to a filter-passing virus. J Comp Pathol Therap 40:144–169Google Scholar
  18. Doyle TM, Wright EC (1950) An inactivated vaccine against Newcastle disease. Br Vet J 106:139–161PubMedGoogle Scholar
  19. Espion D, de Henau S, Letellier C, Wemers CD, Brasseur R, Young JF, Gross M, Rosenberg M, Meulemans G, Burny A (1987) Expression at the cell surface of native fusion protein of the Newcastle disease virus (NDV) strain Italien from cloned cDNA. Arch Virol 95:79–95PubMedCrossRefGoogle Scholar
  20. Fabian Z, Torocsik B, Kiss K, Csatary LK, Bodey B, Tigyi J, Csatary C, Szeberenyi J (2001) Induction of apoptosis by a Newcastle disease virus vaccine (MTH-68/H) in PC12 rat phaeochromocytoma cells. Anticancer Res 21:125–135PubMedGoogle Scholar
  21. Gallili GE, Ben-Nathan D (1998) Newcastle disease vaccines. Biotechnol Adv 16:343–366PubMedCrossRefGoogle Scholar
  22. Gomez Lim MA (2011) Plants as platform for production of pharmaceutical compounds. In: Liong MT (ed) Bioprocess sciences and technology. Nova, New YorkGoogle Scholar
  23. Gomez E, Zoth SC, Carrillo E, Roux ME, Berinstein A (2008) Mucosal immunity induced by orally administered transgenic plants. Immunobiology 213:671–675PubMedCrossRefGoogle Scholar
  24. Gomez E, Zoth SC, Asurmendi S, Rovere CV, Berinstein A (2009) Expression of hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus in agroinfiltrated Nicotiana benthamiana plants. J Biotechnol 144:337–340PubMedCrossRefGoogle Scholar
  25. Guerrero-Andrade O, Loza-Rubio E, Olivera-Flores T, Fehervari-Bone T, Gomez-Lim MA (2006) Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies. Transgenic Res 15:455–463PubMedCrossRefGoogle Scholar
  26. Guèye EF (2002) Newcastle disease in family poultry: prospects for its control through ethnoveterinary medicine. Livest Res Rural Dev 14:1–13Google Scholar
  27. Hahn BS, Jeon IS, Jung YJ, Kim JB, Park JS, Ha SH, Kim KH, Kim HM, Yang JS, Kim YH (2007) Expression of hemagglutinin-neuraminidase protein of Newcastle disease virus in transgenic tobacco. Plant Biotechnol Rep 1:85–92CrossRefGoogle Scholar
  28. Heckert RA, Riva J, Cook S, McMillen J, Schwartz RD (1996) Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens. Avian Dis 40:770–777PubMedCrossRefGoogle Scholar
  29. Hitchner SB, Reising G, Van Roekel H (1951) Intranasal vaccine: its role in an avian pneumoencephalitis control program. Vet Med 46:21PubMedGoogle Scholar
  30. Hughes CS, Gaskell RM, Jones RC, Bradbury JM, Jordan FT (1989) Effects of certain stress factors on re-excretion of infectious laryngotracheitis virus from latently infected cartier birds. Res Vet Sci 46:274–276PubMedGoogle Scholar
  31. Ideris A, Ibrahim AL, Spradbrow PB (1990) Vaccination of chickens against Newcastle disease with a food pellet vaccine. Avian Pathol 19:371–384PubMedCrossRefGoogle Scholar
  32. Jafari RA, Jalali MR, Ghorbanpoor M, Saraei SM (2008) Effect of dietary garlic on immune response of broiler chicks to live Newcastle disease vaccine. Pak J Biol Sci 11:1848–1851PubMedCrossRefGoogle Scholar
  33. Jayawardane GW, Spradbrow PB (1995) Mucosal immunity in chickens vaccinated with the V4 strain of Newcastle disease virus. Vet Microbiol 46:69–77PubMedCrossRefGoogle Scholar
  34. Jayawardane GW, De Alwis MC, Bandara D (1990) Oral vaccination of chickens against Newcastle disease with V4 vaccine delivered on processed rice grains. Aust Vet J 67:364–366PubMedCrossRefGoogle Scholar
  35. King DJ (1999) A comparison of the onset of protection induced by Newcastle disease virus strain B1 and, a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge. Avian Dis 43(4):745–755PubMedCrossRefGoogle Scholar
  36. King DJ (2001) Selection of thermostable Newcastle disease virus progeny from reference and vaccine strains. Avian Dis 45:512–516PubMedCrossRefGoogle Scholar
  37. Lai KS, Yusoff K, Mahmood M (2012) Heterologous expression of hemagglutinin-neuraminidase protein from Newcastle disease virus strain Af2240 in Centella Asiatica. Acta Biol Cracov Bot 54:142–147Google Scholar
  38. Lai KS, Yusoff K, Mahmood M (2013) Functional ectodomain of the hemagglutinin-neuraminidase protein is expressed in transgenic tobacco cells as a candidate vaccine against Newcastle disease virus. Plant Cell Tissue Organ Cult 112:117–121CrossRefGoogle Scholar
  39. Lamphear BJ, Streatfield SJ, Jilka JM, Brooks CA, Barker DK, Turner DD, Delaney DE, Garcia M, Wiggins B, Woodard SL, Hood EE, Tizard IR, Lawhorn B, Howard JA (2002) Delivery of subunit vaccines in maize seed. J Control Release 85:169–180PubMedCrossRefGoogle Scholar
  40. Letellier C, Burny A, Meulemans G (1991) Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge. Arch Virol 118:43–56PubMedCrossRefGoogle Scholar
  41. Loke CF, Omar AR, Raha AR, Yusoff K (2005) Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes. Vet Immunol Immunopathol 106:259–267PubMedCrossRefGoogle Scholar
  42. McGinnes LW, Pantua H, Laliberte JP, Gravel KA, Jain S, Morrison TG (2010) Assembly and biological and immunological properties of Newcastle disease virus-like particles. J Virol 84:4513–4523PubMedCentralPubMedCrossRefGoogle Scholar
  43. McGinnes LW, Gravel KA, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Schmidt MR, Morrison TG (2011) Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins. J Virol 85:366–377PubMedCentralPubMedCrossRefGoogle Scholar
  44. Meszaros JF (1983) Control of infectious diseases in large scale poultry breeding and production. Worlds Poult Sci J 39:132–141CrossRefGoogle Scholar
  45. Meszsaros H (1991) Aerosol immunization against Newcastle disease. Deut Tierarztl Woch 98:123–126Google Scholar
  46. Meulemans G, Letellier C, Gonze M, Carlier MC, Burny A (1988) Newcastle disease virus F glycoprotein expressed from a recombinant vaccinia virus vector protects chickens against live-virus challenge. Avian Pathol 17:821–827PubMedCrossRefGoogle Scholar
  47. Miguel E, Grosbois V, Berthouly-Salazar C, Caron A, Cappelle J, Roger F (2012) A meta-analysis of observational epidemiological studies of Newcastle disease in African agro-systems, 1980–2009. Epidemiol Infect 141:1–17Google Scholar
  48. Mohamed MA, Hanson RP (1980) Effect of social stress on Newcastle disease virus (LaSota) infection. Avian Dis 24:908–915PubMedCrossRefGoogle Scholar
  49. Morgan RW, Gelb J Jr, Schreurs CS, Lutticken D, Rosenberger JK, Sondermeijer PJ (1992) Protection of chickens from Newcastle and Marek’s diseases with a recombinant herpes virus of turkeys vaccine expressing the Newcastle disease virus fusion protein. Avian Dis 36:858–870PubMedCrossRefGoogle Scholar
  50. Mori H, Tawara H, Nakazawa H, Sumida M, Matsubara F, Aoyama S, Iritani Y, Hayashi Y, Kamogawa K (1994) Expression of the Newcastle disease virus (NDV) fusion glycoprotein and vaccination against NDV challenge with a recombinant baculovirus. Avian Dis 38:772–777PubMedCrossRefGoogle Scholar
  51. Morrison TG (2003) Structure and function of a paramyxovirus fusion protein. Biochim Biophys Acta 1614:73–84PubMedCrossRefGoogle Scholar
  52. Morrison TG (2010) Newcastle disease virus-like particles as a platform for the development of vaccines for human and agricultural pathogens. Future Virol 5:545–554PubMedCentralPubMedCrossRefGoogle Scholar
  53. Nagy E, Krell PJ, Dulac GC, Derbyshire JB (1991) Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine. Avian Dis 35:585–590PubMedCrossRefGoogle Scholar
  54. Nishino Y, Niikura M, Suwa T, Onuma M, Gotoh B, Nagai Y, Mikami T (1991) Analysis of the protective effect of the haemagglutinin-neuraminidase protein in Newcastle disease virus infection. J Gen Virol 72(Pt 5):1187–1190PubMedCrossRefGoogle Scholar
  55. Rajput ZI, Xiao CW, Hu SH, Habib M, Soomro NA (2010) Enhancement of immune responses to infectious bursal disease vaccine by supplement of an extract made from Momordica cochinchinensis (Lour.) Spreng. seeds. Poult Sci 89:1129–1135PubMedCrossRefGoogle Scholar
  56. Rao SB, Agarwal KK (1969) Studies on vaccination with lentogenic strains of Newcastle disease virus administered through spray and drinking water. Indian Vet J 46:743–749PubMedGoogle Scholar
  57. Rehmani SF, Spradbrow PB, West R (1995) Lactose pellets–a new approach to oral vaccination of village chickens against Newcastle disease. Vet Microbiol 46:47–53PubMedCrossRefGoogle Scholar
  58. Roy P, Noad R (2009) Virus-like particles as a vaccine delivery system: myths and facts. Adv Exp Med Biol 655:145–158PubMedCrossRefGoogle Scholar
  59. Sakaguchi M, Nakamura H, Sonoda K, Hamada F, Hirai K (1996) Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus. Vaccine 14:747–752PubMedCrossRefGoogle Scholar
  60. Schirrmacher V, Fournier P (2009) Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer. Methods Mol Biol 542:565–605PubMedCrossRefGoogle Scholar
  61. Schoening HW, Osteen OL et al (1949) Vaccination against Newcastle disease with formalin-inactivated, commercially produced vaccines. Am J Vet Res 10:176–182PubMedGoogle Scholar
  62. Seal BS, King DJ, Sellers HS (2000) The avian response to Newcastle disease virus. Dev Comp Immunol 24:257–268PubMedCrossRefGoogle Scholar
  63. Senne DA, King DJ, Kapczynski DR (2004) Control of Newcastle disease by vaccination. Dev Biol 119:165–170Google Scholar
  64. Sharma JM (1999) Introduction to poultry vaccines and immunity. Adv Vet Med 41:481–494PubMedCrossRefGoogle Scholar
  65. Sim JS, Pak HK, Kim DS, Lee SB, Kim YH, Hahn BS (2009) Expression and characterization of synthetic heat-labile enterotoxin B subunit and hemagglutinin-neuraminidase-neutralizing epitope fusion protein in Escherichia coli and Tobacco Chloroplasts. Plant Mol Biol Rep 27:388–399CrossRefGoogle Scholar
  66. Spradbrow PB, Samuel JL (1991) Oral Newcastle disease vaccination with V4 virus in chickens: comparison with other routes. Aust Vet J 68:114–115PubMedCrossRefGoogle Scholar
  67. Steel J, Burmakina SV, Thomas C, Spackman E, Garcia-Sastre A, Swayne DE, Palese P (2008) A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine 26:522–531PubMedCentralPubMedCrossRefGoogle Scholar
  68. Streatfield SJ, Lane JR, Brooks CA, Barker DK, Poage ML, Mayor JM, Lamphear BJ, Drees CF, Jilka JM, Hood EE, Howard JA (2003) Corn as a production system for human and animal vaccines. Vaccine 21:812–815PubMedCrossRefGoogle Scholar
  69. Sullivan JF, Gill E, Somer AM (1958) Immune response of chickens to Betapropiolactone-killed Newcastle disease vaccines. Am J Vet Res 19:483–488PubMedGoogle Scholar
  70. Thomas DR, Penney CA, Majumder A, Walmsley AM (2011) Evolution of plant-made pharmaceuticals. Int J Mol Sci 12:3220–3236PubMedCentralPubMedCrossRefGoogle Scholar
  71. Vagnozzi A, Garcia M, Riblet SM, Zavala G (2010) Protection induced by infectious laryngotracheitis virus vaccines alone and combined with Newcastle disease virus and/or infectious bronchitis virus vaccines. Avian Dis 54:1210–1219PubMedCrossRefGoogle Scholar
  72. Wambura PN (2009) Vaccination of chickens using raw rice coated with novel trehalose nano-organogels containing Newcastle disease (strain I-2) vaccine. Trop Anim Health Prod 41:797–802PubMedCrossRefGoogle Scholar
  73. Xiao C, Bao G, Hu S (2009) Enhancement of immune responses to Newcastle disease vaccine by a supplement of extract of Momordica cochinchinensis (Lour.) Spreng seeds. Poult Sci 88:2293–2297PubMedCrossRefGoogle Scholar
  74. Yang ZQ, Liu QQ, Pan ZM, Yu HX, Jiao XA (2007) Expression of the fusion glycoprotein of Newcastle disease virus in transgenic rice and its immunogenicity in mice. Vaccine 25:591–598PubMedCrossRefGoogle Scholar
  75. Yusibov V, Streatfield SJ, Kushnir N (2011) Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum Vaccin 7:313–321PubMedCrossRefGoogle Scholar
  76. Zhang R, Wang X, Su J, Zhao J, Zhang G (2010) Isolation and analysis of two naturally-occurring multi-recombination Newcastle disease viruses in China. Virus Res 151:45–53PubMedCrossRefGoogle Scholar
  77. Zhao K, Chen G, Shi XM, Gao TT, Li W, Zhao Y, Zhang FQ, Wu J, Cui X, Wang YF (2012) Preparation and efficacy of a live Newcastle disease virus vaccine encapsulated in chitosan nanoparticles. PLoS One 7:e53314PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.CINVESTAV Unidad IrapuatoIrapuatoMexico

Personalised recommendations